Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

被引:12
作者
Gately, Lucy [1 ,2 ]
Jalali, Azim [1 ,2 ,3 ]
Semira, Christine [1 ]
Faragher, Ian [4 ]
Croxford, Matthew [4 ]
Ananda, Sumitra [1 ,2 ,3 ,5 ,6 ]
Kosmider, Suzanne [3 ]
Field, Kathryn [7 ]
Lok, Sheau Wen [1 ,2 ,5 ]
Gard, Grace [1 ]
Steel, Malcolm [8 ]
Lee, Margaret [1 ,2 ,9 ]
Wong, Rachel [1 ,9 ,10 ]
Wong, Hui-Li [1 ,2 ,5 ]
Gibbs, Peter [1 ,2 ,3 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Personalised Oncol Div, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia
[3] Univ Melbourne, Western Hlth Med Sch, Dept Med Oncol, Footscray, Vic, Australia
[4] Univ Melbourne, Western Hlth Med Sch, Dept Surg, Footscray, Vic, Australia
[5] Peter MacCallum Canc Ctr, Dept Oncol, Parkville, Vic, Australia
[6] Epworth Freemasons, East Melbourne, Australia
[7] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia
[8] Eastern Hlth, Dept Surg Oncol, Box Hill, Vic, Australia
[9] Eastern Hlth, Dept Med Oncol, Box Hill, Vic, Australia
[10] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia
关键词
Colorectal cancer; surveillance; survival; staging; INTENSIVE FOLLOW-UP; COLORECTAL-CANCER; CURATIVE RESECTION; AMERICAN SOCIETY; SURVEILLANCE; SURVIVAL; SURGERY; METASTASES; IMPACT;
D O I
10.1080/0284186X.2021.1943519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Multiple meta-analyses have demonstrated that routine surveillance following colorectal cancer surgery improves survival outcomes. There is limited data on how recurrence patterns and post-recurrence outcomes vary by individual tumor stage. Methods Using a multi-site community cohort study, we examined the potential impact of primary tumor stage on the sites of recurrence, management of recurrent disease with curative intent, and post-resection survival. We also explored changes over time. Results Of 4257 new colon cancers diagnosed 2001 through 2016, 789 (21.1%) had stage I, 1584 (42.4%) had stage II, and 1360 (36.4%) had stage III colon cancer. For consecutive 5-year periods (2001-2005, 2006-2010, 2011-2016), recurrence rates have declined (23.4 vs. 17.1 vs. 13.6%, p < 0.001), however, the resection rates of metastatic disease (29.3 vs. 38.6 vs. 35.0%, p = 0.21) and post-resection 5-year survival (52.0 vs. 51.8 vs. 64.2%, p = 0.12) have remained steady. Primary tumor stage impacted recurrence rate (3.8 vs. 12 vs. 28%, p < 0.0001 for stage 1, 2, and 3), patterns of recurrence, resection of metastatic disease, (50 vs. 42 vs. 30%, p < 0.0001) and post-resection 5-year survival (92 vs. 64 vs. 44%, p < 0.001). Conclusion In this community cohort we defined significant differences in recurrence patterns and post-resection survival by tumor stage, with a diminishing rate of recurrence over time. While recurrence rates were lower with stage I and II disease, the high rate of metastatic disease resection and excellent post-resection outcomes help to justify routine surveillance in these patients.
引用
收藏
页码:1106 / 1113
页数:8
相关论文
共 24 条
[1]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[2]   2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines [J].
Benson, AB ;
Desch, CE ;
Flynn, PJ ;
Krause, C ;
Loprinzi, CL ;
Minsky, BD ;
Petrelli, NJ ;
Pfister, DG ;
Smith, TJ ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3586-3588
[3]   Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome [J].
Hohenberger, W. ;
Weber, K. ;
Matzel, K. ;
Papadopoulos, T. ;
Merkel, S. .
COLORECTAL DISEASE, 2009, 11 (04) :354-364
[4]   Follow-up strategies for patients treated for non-metastatic colorectal cancer [J].
Jeffery, Mark ;
Hickey, Brigid E. ;
Hider, Phillip N. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (09)
[5]   Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres - what is current practice? [J].
Kosmider, S. ;
Stella, D. L. ;
Field, K. ;
Moore, M. ;
Ananda, S. ;
Oakman, C. ;
Singh, M. ;
Gibbs, P. .
COLORECTAL DISEASE, 2009, 11 (06) :592-600
[6]   Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement [J].
Meyerhardt, Jeffrey A. ;
Mangu, Pamela B. ;
Flynn, Patrick J. ;
Korde, Larissa ;
Loprinzi, Charles L. ;
Minsky, Bruce D. ;
Petrelli, Nicholas J. ;
Ryan, Kim ;
Schrag, Deborah H. ;
Wong, Sandra L. ;
Benson, Al B., III .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) :4465-+
[7]   Outcome after repeat resection of liver metastases from colorectal cancer [J].
Neeff, Hannes P. ;
Drognitz, Oliver ;
Holzner, Philipp ;
Klock, Andrea ;
Bronsert, Peter ;
Hopt, Ulrich T. ;
Makowiec, Frank .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (08) :1135-1141
[8]   Survival following recurrence in stage II and III colon cancer:: Findings from the ACCENT data set [J].
O'Connell, Michael J. ;
Campbell, Megan E. ;
Goldberg, Richard M. ;
Grothey, Axel ;
Seitz, Jean-Francois ;
Benedetti, Jacqueline K. ;
Andre, Thierry ;
Haller, Daniel G. ;
Sargent, Daniel J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) :2336-2341
[9]   Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population [J].
Osterman, Erik ;
Glimelius, Bengt .
DISEASES OF THE COLON & RECTUM, 2018, 61 (09) :1016-1025
[10]  
Party CCACCGW, 2017, CLIN PRACT GUID PREV